TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM

被引：0
|
作者：
Maervoet, J. [1 ]
Toumi, M. [2 ]
机构：
[1] Deloitte, Diegem, Belgium
[2] Univ Lyon 1, F-69365 Lyon, France
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.674
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A312 / A312
页数：1
相关论文
共 50 条
  • [1] HORIZONTAL VS. VERTICAL EQUITY: MARKET ACCESS OF ORPHAN DRUGS IN FRANCE AND UK
    Korchagina, D.
    Tavella, F.
    Remuzat, C.
    Toumi, M.
    Falissard, B.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [2] MARKET ACCESS OF DRUGS IN FRANCE: EVOLUTION OR REVOLUTION?
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A304 - A304
  • [3] Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
    Pauwels, Kim
    Huys, Isabelle
    Casteels, Minne
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [4] COPD DRUGS IN EUROPE - A COMPARISON OF MARKET ACCESS DECISIONS IN FRANCE, GERMANY, SWEDEN AND UK WITH THE PRISMACCESS DATABASE
    Vollmer, L.
    Walzer, S.
    Droeschel, D.
    de Paz, B.
    VALUE IN HEALTH, 2016, 19 (07) : A561 - A561
  • [5] ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES
    Mennezein, L.
    Avot, D.
    Laigle, V
    VALUE IN HEALTH, 2017, 20 (09) : A565 - A565
  • [6] REGIONAL TIME TO MARKET OF INNOVATIVE DRUGS IN ITALY
    Mantuano, M.
    Daniel, F.
    Urbinati, D.
    VALUE IN HEALTH, 2016, 19 (07) : A451 - A451
  • [7] A COMPARISON STUDY OF PRICES AND MARKET ACCESS DELAYS FOR ATUC DRUGS IN FRANCE VERSUS EU4 & UK
    Gas, N.
    Perez, A.
    Parlato, G.
    Schmid, R.
    Vialard, L.
    VALUE IN HEALTH, 2022, 25 (01) : S181 - S181
  • [8] MARKET ACCESS OF DRUGS IN FRANCE AND MEDICO-ECONOMIC ASSESSMENT
    Remuzat, C.
    Toumi, M.
    Aballea, S.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [9] FACTORS OF ACCESS TO THE MARKET OF INNOVATIVE SPECIALTIES IN ALGERIA: THE CASE OF HOSPITAL DRUGS
    Djafri, R.
    Djemai, S.
    Aissaoui, A.
    Laichour, A.
    Boudis, A.
    VALUE IN HEALTH, 2022, 25 (12) : S258 - S259
  • [10] Accelerating access to innovative oncology drugs: Insights from France's early access reform
    Martin, T.
    Bayle, A.
    Marabelle, A.
    Massard, C. P.
    Borget, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S943 - S943
12345